share_log

Med-X to Attend PestWorld Conference in Boston From October 11-14, 2022

Med-X to Attend PestWorld Conference in Boston From October 11-14, 2022

Med-X 将于 2022 年 10 月 11 日至 14 日参加在波士顿举行的 PestWorld 会议
Accesswire ·  2022/10/10 08:31

Management to Showcase the Nature-Cide Product Portfolio to Industry Decision Makers at Leading Industry Conference

管理层将在领先的行业会议上向行业决策者展示自然-Cide产品组合

LOS ANGELES, CA / ACCESSWIRE / October 10, 2022 / Med-X, Inc., a leading innovator of all-natural green scene solutions addressing the pest control, health and wellness markets, today announced that the Company will attend PestWorld Boston 2022 - a leading event in the pest control industry - taking place October 11-14, 2022 in Boston, Massachusetts.

加利福尼亚州洛杉矶/ACCESSWIRE/2022年10月10日/面向害虫控制、健康和保健市场的全天然绿色场景解决方案的领先创新者Med-X公司今天宣布,该公司将参加2022年10月11日至14日在马萨诸塞州波士顿举行的2022年波士顿害虫世界大会--害虫防治行业的领先活动。

Every year, the National Pest Management Association (NPMA) gathers thousands of pest management professionals and industry suppliers from across the globe to offer opportunities for networking and collaboration at PestWorld. The NPMA, a non-profit organization with nearly 5,000 members from around the world, was established in 1933 to support the pest management industry's commitment to the protection of public health, food and property.

每年,国家害虫管理协会(NPMA)聚集了来自全球各地的数千名害虫管理专业人员和行业供应商,为害虫世界提供联网和合作的机会。NPMA是一个非营利性组织,拥有来自世界各地的近5000名成员,成立于1933年,目的是支持虫害管理行业保护公共健康、食品和财产的承诺。

PestWorld Boston 2022
Date: October 11-14, 2022
Location: John B. Hynes Veterans Memorial Center | Boston, MA
Booth: 1005

波士顿2022年害虫世界
日期:2022年10月11日至14日
地点:约翰·B·海因斯退伍军人纪念中心|马萨诸塞州波士顿
展位:1005

"I look forward to showcasing our Nature-Cide family of products to countless potential customers at PestWorld Boston 2022, a premier event within the broader pest control industry," said Greg Pettis VP of Business Development at Med-X. "Our ability to offer truly safe alternatives to outdated poisonous chemicals often used in pest control has proven popular with consumers and pest control professionals alike, and we are eager to share our capabilities with industry decision makers at PestWorld."

Med-X负责业务发展的副总裁Greg Pettis表示:“我期待着在PestWorld Boston 2022上向无数潜在客户展示我们的Natural-Cide系列产品,这是更广泛的虫害控制行业的一次盛会。”事实证明,我们能够为害虫防治中经常使用的过时有毒化学物质提供真正安全的替代品,受到消费者和害虫防治专业人士的欢迎,我们渴望与PestWorld的行业决策者分享我们的能力。

About Med-X, Inc.

关于Med-X公司

Med-X, Inc. is a leading innovator of all-natural green scene solutions addressing the international pest control, health and wellness markets. Capitalizing on its diverse family of in-house brands to offer safe alternatives to conventional chemical and pharmaceutical products using all-natural ingredients, Med-X's comprehensive go-to-market strategy includes an integrated e-commerce, brick and mortar distributor and on-site services presence in key national markets. For more information, please visit .

Med-X,Inc.是面向国际病虫害防治、健康和保健市场的全天然绿色场景解决方案的领先创新者。Med-X利用其多样化的自有品牌系列,提供使用全天然成分的传统化学和医药产品的安全替代品,其全面的市场进入战略包括在关键的国家市场提供集成的电子商务、实体经销商和现场服务。欲了解更多信息,请访问。

Disclaimer and Forward-Looking Statements

免责声明和前瞻性声明

This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sale of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). This announcement is being issued in accordance with Rule 135 of the Securities Act. This press release may contain forward-looking statements regarding projected business performance, operating results, financial condition, and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The Company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the Company incurring operating losses and experiencing unexpected material adverse events.

本新闻稿不构成出售或邀请购买任何证券的要约。任何购买或出售证券的要约、要约或要约都将根据修订后的1933年证券法(“证券法”)的登记要求进行。本公告是根据《证券法》第135条发布的。本新闻稿可能包含有关公司的预期业务业绩、经营结果、财务状况和其他方面的前瞻性陈述,用“预期”、“预期”、“预计”和“预测”等语言表达。请注意,此类陈述仅为估计,不能保证前瞻性陈述所陈述或暗示的结果将由公司实际实现。前瞻性陈述可能是基于被证明是错误的管理假设。本公司及其业务受到重大风险和非其控制的潜在事件的影响,这些风险和潜在事件将导致预期结果与实际结果之间存在重大差异,包括本公司发生运营亏损和发生意外的重大不利事件。

Investor Relations Contact
Lucas Zimmerman
Director
MZ Group - MZ North America
262-357-2918
MXRX@mzgroup.us

投资者关系联系人
卢卡斯·齐默尔曼
董事
MZ集团-MZ北美
262-357-2918
邮箱:mxrx@mzgroup.us

SOURCE: Med-X, Inc.

资料来源:Med-X公司

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发